Geneus - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $79,800.00 +4.92%
Ethereum $3,211.07 +6.14%
BNB $638.34 +3.04%
Optimism $1.71 +7.35%
Arbitrum $0.64 +8.74%
Solana $211.55 +7.50%
Polygon $0.41 +9.65%
Cosmos $5.42 +15.64%
Avalanche $32.78 +13.64%

Bitcoin $79,800.00 +4.92%
Ethereum $3,211.07 +6.14%
BNB $638.34 +3.04%
Optimism $1.71 +7.35%
Arbitrum $0.64 +8.74%
Solana $211.55 +7.50%
Polygon $0.41 +9.65%
Cosmos $5.42 +15.64%
Avalanche $32.78 +13.64%

Geneus

company

Summary
Funding Rounds
Investors

About

Geneus is a developer of gene sequencers and reagents.

51 - 100

Highlights

Details

Last Funding Type: Series B
Industries: Biotechnology
Founded date: Apr 1, 2017
Number Of Employee: 51 - 100
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

—

Geneus has raised a total of — in funding over 2 rounds. Their latest funding was raised on Sep 28, 2021 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 28, 2021	Series B	—	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

2

Geneus is funded by 2 investors. Darun Touzi and Rays Venture Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Darun Touzi	—	Series B
Rays Venture Capital	—	Series B